跳至主要内容
临床试验/JPRN-UMIN000015430
JPRN-UMIN000015430已完成未知

Drug-drug interaction study of repaglinide with regard to CYP2C8 and OATP1B1 - Drug-drug interaction study of repaglinide

Clinical Pharmacokinetics, Graduate School of Pharmaceutical Sciences, Kyushu University0 个研究点目标入组 24 人开始时间: 2014年10月15日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 45years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • The investigators must ensure that all subjects being considered meet the ollowing exclusion criteria or conditions: 1) history of allergy to any drugs 2) medical attention within 2 months prior to participation 3) donation of 200 mL or more of blood within 4 weeks prior to participation, or donation of component blood within 2 weeks prior to participation 4) donation of 400 mL or more of blood within 12 weeks prior to participation 5) recent (past 4 months) participation in other clinical trial for investigational new chemical entity 6) history of drug abuse 7) alcohol abuse 8) lactose intolerant.

研究者

发起方
Clinical Pharmacokinetics, Graduate School of Pharmaceutical Sciences, Kyushu University

相似试验